Cipher Pharmaceuticals Reports Second Quarter 2025 Results, Including Record Revenue

Stock Information for Helius Medical Technologies Inc. Class A common shares

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Helius Medical Technologies Inc. Class A common shares

Cipher Pharmaceuticals Reports Third Quarter 2025 Results
Cipher Pharmaceuticals Schedules Q3 2025 Earnings Release and Conference Call
Cipher Pharmaceuticals Receives Successful Arbitration Award
Cipher Pharmaceuticals Announces the Passing of Director Mr. Harold Wolkin
Cipher Pharmaceuticals Schedules Q2 2025 Earnings Release and Conference Call
Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders
Cipher Pharmaceuticals Reports First Quarter 2025 Results, and Announces $15 Million Debt Repayment
Cipher Pharmaceuticals Schedules Q1 2025 Earnings Release and Conference Call

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.